Nine more drugmakers strike voluntary drug-pricing deals with the White House, pledging nearly $20B in US investments to avoid tariffs and CMS pricing pilots.
Nine new companies have announced voluntary drug pricing deals with the White House, looking to avoid industry tariffs and inclusion in two CMS pilot programs …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
The deals will build on agreements the administration struck with 17 of the world’s largest drugmakers, including Pfizer, Eli…
The new agreements bring the total number of companies in the administration's most-favored-nation pricing program to 26
The latest companies are expected to avoid tariffs by entering into the "most favored nation" agreements.
President Trump on Monday announced the next round of pricing deals with drugmakers, with nine new companies making such…
President Donald Trump announced nine of the largest drugmakers in the U.S. and Europe agreed to voluntarily sell their…
Nine midsize pharmaceutical companies signed on to most-favored-nation deals with President Donald Trump, lowering drug prices…
Trump announces new drug pricing deals with 9 pharma companies
Trump announces new drug pricing deals with 9 drugmakers
Nine more drugmakers cut pricing deals with Trump
Trump strikes nine more deals with drugmakers to lower prices
Trump announces nine most-favored-nation deals to lower drug prices
White House to announce new drug pricing deals with biotechs: Report
Trump reportedly plans to announce new drug pricing deals with nearly a dozen drugmakers
Trump announces deal with 9 new pharmaceutical firms in move to ease drug costs
White House unveils next round of MFN pricing deals with 9 midsized drugmakers
Sun Pharma among 9 pharmaceutical firms to lower drug prices for Americans, Trump says
